Takeda Sues Apotex Over Generic Actos

Law360, New York (March 23, 2011, 3:13 PM EDT) -- Takeda Pharmaceutical Co. Ltd. launched a patent suit against Apotex Inc. on Tuesday in Florida over the company's efforts to manufacture a generic version of diabetes medication Actos.

In a complaint filed in the U.S. District Court for the Southern District of Florida, Takeda and subsidiary Takeda Pharmaceuticals North America Inc. claim that  Apotex's submission of an abbreviated new drug application for tablets containing pioglitazone infringes seven patents.

Takeda, through its U.S. subsidiary, received permission from the U.S. Food and Drug Administration in July 1999 to...
To view the full article, register now.